Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression

被引:0
|
作者
Tsai, Wei-En [1 ]
Liu, Yen-Tsen [1 ]
Kuo, Fu-Hsuan [2 ]
Cheng, Wen-Yu [3 ,4 ,5 ,6 ]
Shen, Chiung-Chyi [3 ,4 ,7 ]
Chiao, Ming-Tsang [3 ]
Huang, Yu-Fen [3 ]
Liang, Yea-Jiuen [3 ]
Yang, Yi-Chin [3 ]
Hsieh, Wan-Yu [3 ]
Chen, Jun-Peng [8 ]
Liu, Szu-Yuan [9 ,10 ]
Chiu, Cheng-Di [11 ,12 ]
机构
[1] Taichung Municipal Taichung First Sr High Sch, Taichung, Taiwan
[2] Taichung Vet Hosp, Ctr Geriatr & Gerontol, Taichung 40705, Taiwan
[3] Taichung Vet Gen Hosp, Neurol Inst, Dept Minimally Invas Skull Base Neurosurg, Taichung, Taiwan
[4] Hung Kuang Univ, Dept Phys Therapy, Taichung, Taiwan
[5] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan
[6] Natl Chung Hsing Univ, Coll Med, Dept Postbaccalaureate Med, Taichung, Taiwan
[7] Cent Taiwan Univ Sci & Technol, Basic Med Educ, Taichung, Taiwan
[8] Taichung Vet Gen Hosp, Biostat Task Force, Taichung, Taiwan
[9] Taichung Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Oncol Neurosurg Div, Taichung, Taiwan
[10] Natl Chung Hsing Univ, Grad Inst Life Sci, Coll Life Sci, Dept Life Sci, Taichung, Taiwan
[11] China Med Univ Hosp, Spine Ctr, Taichung, Taiwan
[12] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan
关键词
Crocetin; glioblastoma; temozolomide; AKT signaling; cell migration; ACTIVATED PROTEIN-KINASES; MOBILITY GROUP BOX-1; CROCUS-SATIVUS; CELL-MIGRATION; CANCER-CELLS; ENDOTHELIAL-CELLS; GLIOMA CANCER; APOPTOSIS; GROWTH; METASTASIS;
D O I
10.2174/0115672026332275240731054001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Glioblastoma multiforme (GBM) is an aggressive type of braintumor that is difficult to remove surgically. Research suggests that substances from saffron, namely crocetin and crocin, could be effective natural treatments, showing abilities to kill cancer cells. Methods Our study focused on evaluating the effects of crocetin on glioma using the U87 cell line. We specifically investigated how crocetin affects the survival, growth, and spread of glioma cells, exploring its impact at concentrations ranging from 75-150 mu M. The study also included experiments combining crocetin with the chemotherapy drug Temozolomide (TMZ) to assess potential synergistic effects. Results Crocetin significantly reduced the viability, proliferation, and migration of glioma cells. It achieved these effects by decreasing the levels of Matrix Metallopeptidase 9 (MMP-9) and Ras homolog family member A (RhoA), proteins that are critical for cancer progression. Additionally, crocetin inhibited the formation of cellular structures necessary for tumor growth. It blocked multiple points of the Ak Strain Transforming (AKT) signaling pathway, which is vital for cancer cell survival. This treatment led to increased cell death and disrupted the cell cycle in the glioma cells. When used in combination with TMZ, crocetin not only enhanced the reduction of cancer cell growth but also promoted cell death and reduced cell replication. This combination therapy further decreased levels of high mobility group box 1 (HMGB1) and Receptor for Advanced Glycation End-products (RAGE), proteins linked to inflammation and tumor progression. It selectively inhibited certain pathways involved in the cellular stress response without affecting others. Conclusion Our results underscore the potential of crocetin as a treatment for glioma. It targets various mechanisms involved in tumor growth and spread, offering multiple avenues for therapy. Further studies are essential to fully understand and utilize crocetin's benefits in treating glioma.
引用
收藏
页码:320 / 336
页数:17
相关论文
共 50 条
  • [1] Dovitinib enhances temozolomide efficacy in glioblastoma cells
    Thanasupawat, Thatchawan
    Natarajan, Suchitra
    Rommel, Amy
    Glogowska, Aleksandra
    Bergen, Hugo
    Krcek, Jerry
    Pitz, Marshall
    Beiko, Jason
    Krawitz, Sherry
    Verma, Inder M.
    Ghavami, Saeid
    Klonisch, Thomas
    Hombach-Klonisch, Sabine
    MOLECULAR ONCOLOGY, 2017, 11 (08): : 1078 - 1098
  • [2] Regorafenib enhances the efficacy of photodynamic therapy in hepatocellular carcinoma through MAPK signaling pathway suppression
    Zhang, Song
    Zhang, Xiao
    Ren, Yali
    Huang, Lu
    Xu, Weitian
    Wang, Haiping
    Lu, Qiping
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 49
  • [3] MiR-655 ENHANCES THE SENSITIVITY OF GLIOBLASTOMA TO TEMOZOLOMIDE THERAPY
    Ogawa, Daisuke
    Chiocca, E. A.
    Godlewski, Jakub
    NEURO-ONCOLOGY, 2013, 15 : 54 - 54
  • [4] Verapamil Potentiates Temozolomide Anticancer Efficacy through the Intrinsic Apoptotic Pathway in Human Glioblastoma Cells
    Hanif, Farina
    Perveen, Kahkashan
    Simjee, Shabana Usman
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 206 - 206
  • [5] Verapamil potentiates temozolomide anticancer efficacy through the intrinsic apoptotic pathway in human glioblastoma cells
    Hanif, F.
    Perveen, K.
    Simjee, S.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S47 - S47
  • [6] Ellagic Acid Enhances Antitumor Efficacy of Temozolomide in an in vitro Glioblastoma Model
    Cetin, Abdurrahman
    Biltekin, Burcu
    TURKISH NEUROSURGERY, 2020, 30 (06) : 813 - 821
  • [7] Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma
    Yamada, Tetsuya
    Tsuji, Shohei
    Nakamura, Shinsuke
    Egashira, Yusuke
    Shimazawa, Masamitsu
    Nakayama, Noriyuki
    Yano, Hirohito
    Iwama, Toru
    Hara, Hideaki
    JOURNAL OF NEUROSURGERY, 2021, 134 (03) : 701 - 710
  • [8] Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy
    Dhungel, Laxmi
    Rowsey, Mandy E.
    Harris, Cayla
    Raucher, Drazen
    MOLECULES, 2024, 29 (04):
  • [9] Sulforaphene Enhances The Efficacy of Photodynamic Therapy In Anaplastic Thyroid Cancer Through Ras/RAF/MEK/ERK Pathway Suppression
    Chatterjee, Saswata
    Rhee, Yunhee
    Chung, Phil-Sang
    Ge, Rui-Feng
    Ahn, Jin-Chul
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2018, 179 : 46 - 53
  • [10] β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway
    Mu, Lin
    Wang, Tianjiao
    Chen, Yanwei
    Tang, Xinqiang
    Yuan, Yuhui
    Zhao, Yongshun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) : 1427 - 1436